Mechanisms of graft acceptance: Evidence that plasminogen activator controls donor-reactive delayed-type hypersensitivity responses in cardiac allograft acceptor mice

Journal of Immunology

Volumn 164, Issue 10, 2000, Pages 5132-5139

  Bickerstaff, Alice A ^a,b   Xia, Dongyuan ^a   Pelletier, Ronald P ^a   Orosz, Charles G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM NITRATE; PLASMIN; PLASMINOGEN ACTIVATOR; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; FIBRINOLYSIS; HEART TRANSPLANTATION; HISTOLOGY; IMMUNOREGULATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034657904     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.10.5132     Document Type: Article

References (45)

1. Madsen, J. C., W. N. Peugh, K. J. Wood, and P. J. Morris. 1987. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts. Transplantation 44:849.
2. + T cell regulation during the induction phase of the response. Eur. J. Immunol. 25:2643.
3. Orosz, C. G., E. Wakely, S. D. Bergese, A. M. VanBuskirk, R. M. Ferguson, D. Mullet, G. Apseloff, and N. Gerber. 1996. Prevention of murine cardiac allograft rejection with gallium nitrate: comparison with anti-CD4 mAb. Transplantation 61:783.
4. Pearson, T. C., D. Z. Alexander. K. J. Winn, P. S. Linsley, R. P. Lowry, and C. P. Larsen. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701.
5. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R.-Q. Wei, M. L. Gibson, X.-G. Zheng, S. Myrdal, D. Gordon, et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89:11102.
6. VanBuskirk, A. M., M. E. Wakely, J. H. Sirak, and C. G. Orosz. 1998. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 65:1115.
7. Davies, J. D., L. Y. W. Leong, A. Mellor, S. P. Cobbold, and H. Waldmann. 1996. T cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156:3602.
8. Bickerstaff, A. A., A. M. VanBuskirk, E Wakely, and C. G. Orosz. 2000. TGF-β and IL-10 subvert DTH alloreactivity in cardiac allograft acceptor mice. Transplantation. In press.
9. D'Orazio, T. J., and J. Y. Niederkorn. 1998. A novel role for TGF-β and IL-10 in the induction of immune privilege. J. Immunol. 160:2089.
10. Takeuchi, M., P. Alard, and J. W. Streilein. 1998. TGF-β promotes immune deviation by altering accessory signals of antigen-presenting cells. J. Immunol. 160:1589.
11. Wilbanks, G. A., M. Mammolenti, and J. W. Streilein. 1998. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22:165.
12. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth faclor-β1. J. Immunol. 146:1163.
13. Chen, Y., V. K. Kuchroo, J.-I. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
14. Lyons, R. M., L. E. Gentry, A. F. Purchio, and H. L. Moses. 1990. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol. 110:1361.
15. Kroon, M. E., P. Koolwijk, H. van Goor, U. H. Weidle, A. Collen, G. van der Pluijm, and V. W. van Hinsbergh. 1999. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am. J. Pathol. 154:1731.
16. Letterio, J. J., and A. B. Roberts. 1998. Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 16:137.
17. Corry, R., H. Winn, and P. Ressell. 1973. Primarily vascularized allografts of hearts in mice. Transplantation 16:341.
18. Sirak, J., C. G. Orosz, E. Wakely, and A. M. VanBuskirk. 1997. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation 63:1300.
19. Engers, H., K. Thomas, J. C. Cerottini, and K. Brunner. 1975. Generations of cylotoxic T lymphocytes in immune spleen cells to subcellular alloantigens. J. Immunol. 115:356.
20. Munger, J. S., J. G. Harpel, P.-E. Gleizes, R. N. Mazzieri, R. and D. B. Rifkin. 1997. Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int. 51:1376.
21. Reiter, L. S., O. Spertini, and E. K. Kruithof. 1997. Plasminogen activators play an essential role in extracellular-matrix invasion by lymphoblastic T cells. Int. J. Cancer 70:461.
22. Orosz, C. G., R. G. Ohye, R. P. Pelletier, A. M. VanBuskirk, E. H. Huang, C. J. Morgan, P W. Kincade, and R. M. Ferguson. 1993. Treatment with antivascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance. Transplantation 56:453.
23. Orosz, C. G., E. Wakely, D. D. Sedmak, S. D. Bergese, and A. M. VanBuskirk. 1997. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody. Transplantation 63:1109.
24. Orosz, C. G., E. H. Huang, S. D. Bergese, D. D. Sedmak, D. J. Birmingham, R. G. Ohye, and A. M. VanBuskirk. 1997. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodeling. J. Heart Lung Transplant. 16:889.
25. Takeuchi, M., M. M. Kosiewicz, P. Alard, and J. W. Streilein. 1997. On the mechanisms by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation. Eur. J. Immunol. 27:1648.
26. Josien, R., P. Douillard, C. Guillot, M. Muschen, I. Anegon, J. Chetruitt, S. Menoret, C. Vignes, J. P. Soulillou, and M.-C. Cuturi. 1998. A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance. J. Clin. Invest. 102:1920.
27. Taipale, J., J. Saharinen, K. Hedman, and J. Keski-Oja. 1996. Latent transforming growth factor-β1 and its binding protein are components of extracellular matrix microfibrils. J. Histochem. Cytochem. 44:875.
28. Schultz-Cherry, S., J. Lawler, and J. E. Murphy-Ullrich. 1994. The type I repeats of thrombospondin 1 activate latent transforming growth factor-β. J. Biol. Chem. 269:26783.
29. Kramer, M. D., H. Spring, R. F. Todd, and U. Vettel. 1994. Urokinase-type plasminogen activator enhances invasion of human T cells (Jurkat) into a fibrin matrix. J. Leukocyte Biol. 56:110.
30. Nykjaer, A., B. Møller, R. F. r. Todd, T. Christensen, P. A. Andreasen, J. Gliemann, and C. M. Petersen. 1994. Urokinase receptor. An activation antigen in human T lymphocytes. J. Immunol. 152:505.
31. Gundersen, D., C. Trân-Thang, B. Sordat, F. Mourali, and C. Rüegg. 1997. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J. Immunol. 158:1051.
32. Falcone, D. J., T. A. McCaffrey, A. Haimovitz-Friedman, and M. Garcia. 1993. Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. 155:595.
33. Falcone, D. J., T. A. McCaffrey, J. Mathew, K McAdam, and W. Borth. 1995. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-β1 via increased expression of urokinase and the urokinase receptor. J. Cell Physiol. 164:334.
34. Hart, P. H., D. R. Burgess, G. F. Vitti, and J. A. Hamilton. 1989. Interleukin-4 stimulated human monocytes to produce tissue-type plasminogen activator. Blood 74:1222.
35. Reidy, M. A., C. Irvin, and V. Lindner. 1996. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ. Res. 78:405.
36. Schäfer, B. M., K. Maier, U. Eickhoff, R. F. Todd, and M. D. Kramer. 1994. Plasminogen activation in healing human wounds. Am. J. Pathol. 144:1269.
37. + T-cell subset inhibits antigen-specific T-Cell responses and prevents colitis. Nature 389:737.
38. Pardoux, C., X. Ma, S. Gobert, S. Pellegrini, P. Mayeux, F. Gay, G. Trinchieri, and S. Chouaib. 1999. Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-β: relationship with IL-12 signaling. Blood 93:1448.
39. Hirsch, C. S., R. Hussain, Z. Toossi, G. Dawood, F. Shahid, and J. J. Ellner. 1996. Cross-modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon γ production. Proc. Natl. Acad. Sci. USA 93:3193.
40. Duval-Jobe, C., M. Leeson, A. Rawitch, and M. J. Parmely. 1995. Mechanism by which U937 promonocytic cells inactivate human interferon-γ. J Interferon Cytokine Res. 15:557.
41. Gonias, S. L., W. W. J. Young, and J. W. Fox. 1989. Cleavage of recombinant murine interferon-γ by plasmin and miniplasmin. J. Interferon Res. 9:517.
42. Bemelman, F., K. Honey, E. Adams, S. Cobbold, and H. Waldmann. 1998. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J. Immunol. 160:2645.
43. Estes, D. M., W. Tuo, W. C. Brown, and J. Goin. 1998. Effects of type I/type II interferons and transforming growth factor-β on B-cell differentiation and proliferation: definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression Immunology 95:604.
44. Russell, P. S., C. M. Chase, and R. B. Colvin. 1997. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 64:1531.
45. Orosz, C. G. 1996. Local cellular immunology of experimental transplant vascular sclerosis. Clin. Transplant. 10:100.